ACADIA Pharmaceuticals
ACAD
#3766
Rank
S$4.49 B
Marketcap
S$26.23
Share price
-1.01%
Change (1 day)
-7.86%
Change (1 year)

ACADIA Pharmaceuticals (ACAD) Fails to deliver data

Key failure to deliver metrics for ACADIA Pharmaceuticals:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for ACADIA Pharmaceuticals (ACAD) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for ACADIA Pharmaceuticals (ACAD) - since 2013

Volume in USD (price x number of shares), data since 2013

ACADIA Pharmaceuticals (ACAD) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2026S$5.41 M-22.03%
2025S$6.94 M-38.86%
2024S$11.35 M38.05%
2023S$8.22 M-40.53%
2022S$13.82 M-74.37%
2021S$53.95 M331.32%
2020S$12.5 M-67.15%
2019S$38.08 M-55.46%
2018S$85.49 M16.96%
2017S$73.09 M-16.52%
2016S$87.57 M150.41%
2015S$34.97 M-4.6%
2014S$36.65 M225.43%
2013S$11.26 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Johnson & Johnson
JNJ
S$67.61 MS$0.17 B๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$57.33 MS$0.15 B๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$58.79 MS$0.42 B๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$21.15 MS$68.65 M๐Ÿ‡บ๐Ÿ‡ธ USA
Vanda Pharmaceuticals
VNDA
S$0.21 MS$1.21 M๐Ÿ‡บ๐Ÿ‡ธ USA